Amantadine‐Induced Craniofacial Myoclonus: Distinctive Iatrogenic Dysarthria in Parkinson's Disease

BACKGROUND: Amantadine is a widely prescribed medication in Parkinson's disease (PD). A distinctive craniofacial distribution of myoclonus with speech impairment is an underrecognized iatrogenic complication in amantadine‐treated patients with PD. CASES: We report 7 patients with idiopathic PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Iris, Armengou‐Garcia, Laura, Sasikumar, Sanskriti, Kuhlman, Greg, Fox, Susan H., Lang, Anthony E., Espay, Alberto J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Case Series with Literature Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525052/
https://www.ncbi.nlm.nih.gov/pubmed/37772280
http://dx.doi.org/10.1002/mdc3.13828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525052/
https://www.ncbi.nlm.nih.gov/pubmed/37772280
http://dx.doi.org/10.1002/mdc3.13828

Ejemplares similares